To fulfill tlie new NCATS vision for the CTSA Consortium and accelerate scientific discoveries into improved outcomes for patients, academic health and science systems must invest, transform, and innovate to optimize their unique strengths. Our vision, aligned with that of NCATS, is to create a research environment at Duke that stimulates the translation of scientific discovery from bench to bedside by 1) linking discovery science to a creative engine that efficiently accelerates development of new technologies;and 2) integrating clinical trials, registries, and electronic health records in a learning health system where research and practice form a continuum. Our research environment will be driven by scientific merit and societal need, """"""""agnostic"""""""" to disease or specialty discipline, aligned with our updated institutional framework for research oversight and quality, and continually evaluated for academic productivity, efficiency, and cost. To achieve these goals, we will create an Integrated Home for clinical and translational research by providing infrastructure and resources to serve investigators and trainees across the research spectrum. We will offer resources based upon common needs among our researchers, including education, biostatistics, biobanking, regulatory expertise, ethics, pilot funding and recruitment assistance. We will also tailor our offerings to specialized needs across research communities that include early translation, proof of concept, site-based research and population based research, which includes multi-site trials, outcomes, health services, implementation science and community engaged research. Integrating these resources will require a new tool, a portal for all trainees and investigators, MyResearchHome@Duke, and its human counterpart, MyResearchTeam@Duke. These tools will provide a single point of entry for all clinical and translational research at Duke, regardless of their department or school. Thus, we will enhance our Integrated Home for clinical and translational research with a combination of sophisticated information technology and mentoring and navigation;provide access to common and specialized resources for all of our translational research communities and train the next generation of researchers in our educational and training programs.
The CTSA will foster the translational research process, ensuring that new discoveries are developed and evaluated more quickly and that clinical research is done with high quality, efficiency, safety and cost- effectiveness.
|Jackson, W; Hornik, C P; Messina, J A et al. (2017) In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia. J Perinatol 37:853-856|
|Gonzalez, Daniel; Bradley, John S; Blumer, Jeffrey et al. (2017) Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J 36:645-653|
|Mahmood, K; Ebner, L; He, M et al. (2017) Novel Magnetic Resonance Imaging for Assessment of Bronchial Stenosis in Lung Transplant Recipients. Am J Transplant 17:1895-1904|
|Virkud, Yamini V; Burks, A Wesley; Steele, Pamela H et al. (2017) Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol 139:882-888.e5|
|Xie, Jichun; Kang, Jian (2017) High-dimensional tests for functional networks of brain anatomic regions. J Multivar Anal 156:70-88|
|Hall, Rasheeda K (2017) Reply to: Comment on: ""Incorporating Geriatric Assessment into a Nephrology Clinic: Preliminary Data from Two Models of Care"". J Am Geriatr Soc 65:880|
|Lee, Jin A; Sauer, Brooke; Tuminski, William et al. (2017) Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia. Am J Perinatol 34:458-464|
|Cary Jr, Michael P; Prvu Bettger, Janet; Jarvis, Jessica M et al. (2017) Successful Community Discharge Following Postacute Rehabilitation for Medicare Beneficiaries: Analysis of a Patient-Centered Quality Measure. Health Serv Res :|
|Patel, Ravi M; Zimmerman, Kanecia; Carlton, David P et al. (2017) Early Caffeine Prophylaxis and Risk of Failure of Initial Continuous Positive Airway Pressure in Very Low Birth Weight Infants. J Pediatr 190:108-111.e1|
|Wang, Laura A; Gonzalez, Daniel; Leeder, J Steven et al. (2017) Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation. J Clin Pharmacol 57:230-234|
Showing the most recent 10 out of 244 publications